A new study is investigating whether FAST MRI, a new type of scan, can help detect small but aggressive breast cancers earlier. Now open to patients, the

Background Drug-related deaths have substantially increased over the past decade in the UK, particularly in Scotland. Co-use of opioids and benzodiazepines (prescribed and/or illicit) is contributing to rising mortality. This study identified motivations in people’s co-use with the aim of informing prescribing and harm reduction interventions to address drug-related deaths. Methods We interviewed 48 people who co-use opioids and benzodiazepines and/or z-drugs (zopiclone and zolpidem) in Glasgow (n = 28), Teesside (n = 10) and Bristol (n = 10). Most participants self-identified as male (n = 37, 77%), white (n = 45, 94%) and had a mean age of 43 years (range: 25–61 years). The majority reported at least one overdose experience, and poor mental health including trauma. Interviews were semi-structured, conducted by an academic and/or peer researcher, and analysed using reflexive thematic analysis. Results Participants’ motivations for co-using mapped onto two interlinked meta-themes: (1) Functional motivations included co-using to augment drug effects, self-medicate or help to generate income. (2) Experiential motivations described participants’ desires to achieve a ‘buzz’ (feeling energised), ‘glow’ (feeling comforted), ‘oblivion’ (escaping trauma and adversity), and ‘gouching’ (physical and mental sensations of ebbing in and out of glow and oblivion). Functional and experiential motivations were dynamic, interrelated and often co-occurred. Conclusions The importance of assessing motivations to co-use should be routinely recognised as part of harm reduction and medication assisted treatments to reduce mortality risk.

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

People with schizophrenia and bipolar disorder gain 5kg in five years. The average person gains 1.5kg.

Excess weight is common in people with severe mental illness, including schizophrenia spectrum disorders, bipolar disorder, and other non-organic psyc…

This review highlights the important role primary care plays in obesity management, using England as an example. It includes a comprehensive summary of current management and referral options for pri...

Community pharmacies should be at the heart of HIV prevention efforts by raising awareness of and providing access to PrEP (pre-exposure prophylaxis), according to a new policy briefing from the University of Bristol. PrEP is a pill that prevents HIV transmission.

Microsoft Virtual Events Powered by Teams